Clinician Summary
High Body Mass Index in Children and Adolescents: Interventions
June 18, 2024
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.
What does the USPSTF recommend? | Children and adolescents 6 years or older: Clinicians should provide or refer children and adolescents 6 years or older with a high body mass index (BMI) (≥95th percentile for age and sex) to comprehensive, intensive behavioral interventions. Grade: B |
To whom does this recommendation apply? | This recommendation applies to all children and adolescents 6 years or older. |
What’s new? | This recommendation is consistent with the 2017 USPSTF recommendation statement on screening for obesity in children and adolescents. |
How to implement this recommendation? |
|
What additional information should clinicians know about this recommendation? | The USPSTF recognizes the challenges that the families of children and adolescents encounter in accessing effective, intensive behavioral interventions for high BMI. Identifying high BMI and how to address it are important steps in helping children and adolescents and their families obtain the support they need. |
Why is this recommendation and topic important? | Approximately 19.7% of children and adolescents aged 2 to 19 years in the US have a BMI at or above the 95th percentile for age and sex, based on Centers for Disease Control and Prevention growth charts from 2000. The prevalence of high BMI increases with age and is higher among Hispanic/Latino, Native American/Alaska Native, and non-Hispanic Black children and adolescents and children from lower-income families. |
What are other relevant USPSTF recommendations? | The USPSTF has issued recommendation statements on screening for high blood pressure in children and adolescents, screening for lipid disorders in children and adolescents, and screening for prediabetes and type 2 diabetes in children and adolescents. Current versions of these and other related USPSTF recommendations are available at https://www.uspreventiveservicestaskforce.org. |
What are additional Tools and Resources? |
|
Where to read the full recommendation statement? | Visit the USPSTF website (https://www.uspreventiveservicestaskforce.org/) or the JAMA website (https://jamanetwork.com/collections/44068/united-states-preventive-services-task-force) to read the full recommendation statement. This includes more details on the rationale of the recommendation, including benefits and harms; supporting evidence; and recommendations of others. |
The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation.